Show All
Where is Vir’s corporate headquarters?
499 Illinois Street, Suite 500, San Francisco, California 94158. Vir also has additional operations in Bellinzona, Switzerland; Boston, Massachusetts; Portland, Oregon; and San Diego, California.
Where is Vir incorporated?
Vir was incorporated in Delaware in April 2016
Who is Vir’s transfer agent and how do I contact them?
Vir’s transfer agent is Computershare Trust Company, N.A. Please see below for the transfer agent contact information:

Computershare Trust Company, N.A.
P.O. Box 30170
College Station, TX 77842-3170

Phone : (800) 710-0940



When did Vir go public?
Vir’s common stock began trading on the on the Nasdaq Global Select Market on October 11, 2019.
On which exchange is Vir listed and what is the ticker symbol?
Vir's common stock is traded on the Nasdaq Global Select Market under the symbol “VIR.”
How can I purchase shares?
Shares can be purchased through any registered broker. Vir does not have a direct stock purchase plan.
Does Vir pay dividends and have a dividend reinvestment program?
Currently, Vir does not pay dividends or offer a dividend reinvestment program.
What is Vir’s CUSIP number?
92764N 10 2.
What is Vir’s fiscal year-end?
Vir's fiscal year-end is December 31st.
Who are Vir’s independent auditors?
Ernst & Young LLP.
Where can I find recent Vir press releases?
You can view Vir’s recent press releases by visiting the Press Releases section of the website.
How can I sign up to receive Vir’s press releases and other company information?
Please visit the Investor Resources section of our website and choose the Email Alerts button to be added to the Vir distribution list.
How can I view documents Vir has filed with the Securities and Exchange Commission (SEC), including Forms 10-K and 10-Q?
Quarterly and annual reports, as well as other SEC filings, can be accessed in the Financial Information section of our Investors Relations website page or directly from the SEC at www.sec.gov.
If I have questions regarding Vir that have not been answered, whom should I contact?
Investor relations inquiries may be submitted by email to IR@vir.bio. Please include your name and phone number with your email correspondence.